搜尋
Liminatus Pharma Ord Shs Class A
LIMN添加自選
4.180USD
+0.150+3.72%
收盤 09-24 16:00（美東）
280.73M總市值
虧損本益比TTM
關於 公司
Liminatus Pharma Ord Shs Class A 簡介
公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -
Liminatus Pharma Ord Shs Class A公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Sang-jin (Daniel) Lee, Ph.D.
Dr. Sang-jin (Daniel) Lee, Ph.D.
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong Chul Yoo, Ph.D.
Dr. Byong Chul Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Dr. Beom K. Choi
Dr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Independent Director
Independent Director
--
--
Mr. Richard Baek
Mr. Richard Baek
Independent Director
Independent Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
333.00
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Sang-jin (Daniel) Lee, Ph.D.
Dr. Sang-jin (Daniel) Lee, Ph.D.
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong Chul Yoo, Ph.D.
Dr. Byong Chul Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
常見問題
Liminatus Pharma Ord Shs Class A的前五大股東是誰？
Liminatus Pharma Ord Shs Class A的前五大股東如下：Mr. Nicholas Fernandez